<DOC>
	<DOCNO>NCT01645384</DOCNO>
	<brief_summary>The purpose study monitor clinical status , adverse event laboratory investigation assess relative safety tolerance Atorvastatin formulation fast condition .</brief_summary>
	<brief_title>Bioequivalence Study Atorvastatin Calcium Tablets , 40 mg Under Fasting Conditions</brief_title>
	<detailed_description>An open-label , randomize , single oral dose , two way crossover bioequivalence study compare Atorvastatin Calcium 40 mg Tablets Dr.Reddy 's Lipitor® 40 mg Tablets Pfizer 74 healthy , adult , human study participant fast condition .</detailed_description>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>He/She provide write informed consent . He/She must healthy adult within 1845 year age ( inclusive ) . He/She Body mass index ≥ 18.5 kg/m2 ≤ 25 kg/m2 , body weight less 50 kg . He/She systolic blood pressure upper limit le 140 mmHg low limit equal 90 mm Hg . Similarly diastolic blood pressure upper limit le 90 mm Hg low limit equal 60 mmHg . He/She must normal health determine medical history physical examination perform within 21 day prior dose period 1 . He/She normal ECG , chest Xray vital sign . Availability study volunteer entire study period willingness adhere protocol requirement evidence write informed consent . If study volunteer female child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . postmenopausal least 1 year . surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform study volunteer ) He/She incapable understanding informed consent . He/She history hypersensitivity idiosyncratic reaction study drug relate drug . He/She evidence impairment renal , hepatic , cardiac , lung gastrointestinal function . Study volunteer history tuberculosis , epilepsy , asthma ( past 5 year ) , diabetes , psychosis glaucoma eligible study . He/She smoke regularly ten cigarette daily difficulty abstain smoke duration study period . He/She take counter prescribed medication , include enzyme modifying drug systemic medication within past 30 day prior dose first period . He/She history psychiatric illness , may impair ability provide write , informed consent . He/She history alcohol substance abuse within last 5 year . He/She clinically significant abnormal value laboratory parameter . He/She participate clinical investigation use experimental drug bleed 350 mL past 3 month . He/She unable likely noncompliant protocol requirement restriction . He/She , study drug contraindicate medical reason He/She intolerant venipuncture . Female volunteer use implant injected hormonal contraceptive anytime 6 month prior study use hormonal contraceptive within 14 day dose . Female volunteer demonstrate positive pregnancy screen . Each female study volunteer screen pregnancy screening , checkin study period . Study volunteer positive inconclusive result withdrawn study . Female volunteer currently breast feed . Female study volunteer pregnant , breastfeed likely become pregnant study allow participate . Female study volunteer child bear potential must either abstain sexual intercourse use reliable barrier method ( e.g . condom , IUD ) contraception course study ( first dose last blood collection ) allow participate . He/She positive urine screen drug abuse time admission checkin period exclude study . He/She , meet inclusion exclusion criterion , verify medical investigator per source document duly authenticate reflect clinical judgment require</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Atorvastatin calcium</keyword>
	<keyword>crossover</keyword>
</DOC>